These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 24338719)

  • 1. Prevalence and correlates of patient-reported symptoms and comorbidities in breast cancer survivors at a tertiary center.
    Mustafa Ali M; Moeller M; Rybicki L; Moore HCF
    J Cancer Surviv; 2017 Dec; 11(6):743-750. PubMed ID: 28283875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of Life, Mood, and Prognostic Understanding in Patients with Metastatic Breast Cancer.
    Shin JA; El-Jawahri A; Parkes A; Schleicher SM; Knight HP; Temel JS
    J Palliat Med; 2016 Aug; 19(8):863-9. PubMed ID: 27124211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Symptoms on Quality of Life during Chemotherapy in African-American Women with Breast Cancer.
    Gaton-Johansson F; Watkins CC; Kanu IK; Whitehouse E; Sarenmalm EK; Brovall M; Kozachik SL
    J Natl Black Nurses Assoc; 2015 Dec; 26(2):7-16. PubMed ID: 27045153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of chemotherapy for breast cancer on sexual function and health-related quality of life.
    Farthmann J; Hanjalic-Beck A; Veit J; Rautenberg B; Stickeler E; Erbes T; Földi M; Hasenburg A
    Support Care Cancer; 2016 Jun; 24(6):2603-9. PubMed ID: 26728760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial.
    Cortes J; Hudgens S; Twelves C; Perez EA; Awada A; Yelle L; McCutcheon S; Kaufman PA; Forsythe A; Velikova G
    Breast Cancer Res Treat; 2015 Dec; 154(3):509-20. PubMed ID: 26567010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study.
    Cleeland CS; Mayer M; Dreyer NA; Yim YM; Yu E; Su Z; Mun Y; Sloan JA; Kaufman PA
    Breast; 2014 Dec; 23(6):763-9. PubMed ID: 25193423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of chemotherapy versus hormonal therapy and health outcomes among patients with hormone receptor-positive, HER2-negative metastatic breast cancer: experience from the patient perspective.
    Gupta S; Zhang J; Jerusalem G
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):929-40. PubMed ID: 25130198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered resting-state hippocampal functional connectivity in breast cancer survivors with chemotherapy-induced amenorrhea.
    Zhuang Y; Guo L; Huang W; Bo G; Zhang J; Zhu Z; Feng Y
    Brain Behav; 2023 Jun; 13(6):e3039. PubMed ID: 37157937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients.
    Wu X; Ye C; Wang X; Cai R; Yang J; Yu X; Zhou Y; Shen L; Zhu Y; Liu X
    Cancer Manag Res; 2021; 13():1517-1527. PubMed ID: 33623431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of 3-week intervention of Shi Quan Da Bu Tang for alleviating hematotoxicity among patients with breast carcinoma receiving chemotherapy.
    Huang SM; Chien LY; Tai CJ; Chiou JF; Chen CS; Tai CJ
    Integr Cancer Ther; 2013 Mar; 12(2):136-44. PubMed ID: 22801942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study.
    Yoo C; Yun MR; Ahn JH; Jung KH; Kim HJ; Kim JE; Park JY; Park KO; Yoon DH; Kim SB
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):565-75. PubMed ID: 23842722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study: application of hemoglobin and cortisol levels, and a memory test to evaluate the quality of life of breast cancer patients on chemotherapy.
    Loo WT; Yip MC; Chow LW; Liu Q; Ng EL; Wang M; Chen J
    Int J Biol Markers; 2013 Dec; 28(4):e348-56. PubMed ID: 24338719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
    Foukakis T; von Minckwitz G; Bengtsson NO; Brandberg Y; Wallberg B; Fornander T; Mlineritsch B; Schmatloch S; Singer CF; Steger G; Egle D; Karlsson E; Carlsson L; Loibl S; Untch M; Hellström M; Johansson H; Anderson H; Malmström P; Gnant M; Greil R; Möbus V; Bergh J;
    JAMA; 2016 Nov; 316(18):1888-1896. PubMed ID: 27825007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls.
    Ando-Tanabe N; Iwamitsu Y; Kuranami M; Okazaki S; Yasuda H; Nakatani Y; Yamamoto K; Watanabe M; Miyaoka H
    Breast Cancer; 2014 Jul; 21(4):453-62. PubMed ID: 22976288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients.
    Sanna G; Pestrin M; Zafarana E; Biagioni C; Cavaciocchi D; Turner N; Di Leo A; Biganzoli L
    Breast; 2013 Oct; 22(5):926-32. PubMed ID: 23707082
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.